We are live on ! Find out more
Los Angeles Capital Management

Los Angeles Capital Management Portfolio holdings

AUM $25.4B
1-Year Est. Return 38.46%
This Fund
S&P 500
This Quarter Est. Return
+13.32%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.25%
AUM
$29.5B
AUM Growth
+$2.76B
Cap. Flow
+$238M
Cap. Flow %
0.81%
Top 10 Hldgs %
40.87%
Holding
1,571
New
251
Increased
436
Reduced
548
Closed
227

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$251M
2
AAPL icon
Apple
AAPL
+$168M
3
AMD icon
Advanced Micro Devices
AMD
+$152M
4
GILD icon
Gilead Sciences
GILD
+$139M
5
PLTR icon
Palantir
PLTR
+$137M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$362M
2
TSLA icon
Tesla
TSLA
+$233M
3
COST icon
Costco
COST
+$192M
4
WMT icon
Walmart Inc
WMT
+$167M
5
MA icon
Mastercard
MA
+$161M

Sector Composition

Rank Sector Weight
1 Technology 37.6%
2 Communication Services 12.78%
3 Healthcare 12.39%
4 Financials 10.47%
5 Industrials 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRRK icon
1526
Scholar Rock
SRRK
$6.55B
-11,575
Closed -$410K
SSB icon
1527
SouthState Bank Corp
SSB
$10.7B
-3,603
Closed -$332K
SSBK
1528
DELISTED
Southern States Bancshares
SSBK
-10,135
Closed -$369K
STLD icon
1529
Steel Dynamics
STLD
$37.7B
-5,998
Closed -$768K
SVRA icon
1530
Savara
SVRA
$1.17B
-30,395
Closed -$69.3K
SWIM icon
1531
Latham Group
SWIM
$921M
-10,410
Closed -$66.4K
SWTX
1532
DELISTED
SpringWorks Therapeutics
SWTX
-8,295
Closed -$390K
TENB icon
1533
Tenable Holdings
TENB
$4.08B
-37,252
Closed -$1.26M
TMCI icon
1534
Treace Medical Concepts
TMCI
$309M
-41,062
Closed -$241K
TRVI icon
1535
Trevi Therapeutics
TRVI
$2.53B
-16,379
Closed -$89.6K
TSE
1536
DELISTED
Trinseo
TSE
-34,760
Closed -$108K
TSHA icon
1537
Taysha Gene Therapies
TSHA
$2.05B
-117,740
Closed -$272K
TTGT icon
1538
TechTarget
TTGT
$265M
-11,580
Closed -$90K
TTMI icon
1539
TTM Technologies
TTMI
$14.5B
-17,453
Closed -$712K
TWST icon
1540
Twist Bioscience
TWST
$7.85B
-12,214
Closed -$449K
UE icon
1541
Urban Edge Properties
UE
$2.75B
-34,731
Closed -$648K
ULCC icon
1542
Frontier Group Holdings
ULCC
$1.54B
-251,780
Closed -$914K
UNF icon
1543
Unifirst Corp
UNF
$5.24B
-1,780
Closed -$335K
UNFI icon
1544
United Natural Foods
UNFI
$2.9B
-15,630
Closed -$364K
USNA icon
1545
Usana Health Sciences
USNA
$250M
-11,972
Closed -$366K
UTMD icon
1546
Utah Medical Products
UTMD
$230M
-11,685
Closed -$665K
VCEL icon
1547
Vericel Corp
VCEL
$2.29B
-6,779
Closed -$288K
VERV
1548
DELISTED
Verve Therapeutics
VERV
-69,083
Closed -$776K
VNDA icon
1549
Vanda Pharmaceuticals
VNDA
$314M
-44,696
Closed -$211K
VRSN icon
1550
VeriSign
VRSN
$25.6B
-70,093
Closed -$20.2M

Similar funds

Los Angeles Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Los Angeles Capital Management held 1,571 positions worth $29.5B, up 10% from $26.7B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Los Angeles Capital Management's Q3 2025 filing shows 251 new, 436 increased, 548 reduced and 227 closed positions. Its largest new stake was eBay: 1,249,162 shares worth $114M. The largest sale was Visa, an estimated $362M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Communication Services and Healthcare.

  • Los Angeles Capital Management's largest Q3 2025 buy was eBay: 1,249,162 shares worth $114M.
  • Los Angeles Capital Management added most to NVIDIA in Q3 2025, an estimated $251M increase.
  • Los Angeles Capital Management's biggest Q3 2025 reduction was Visa, cutting an estimated $362M.
  • Los Angeles Capital Management fully exited VeriSign in Q3 2025, selling an estimated $20.2M.
  • Los Angeles Capital Management's ten largest holdings make up 41% of its $29.5B portfolio in Q3 2025.
  • Los Angeles Capital Management opened 251 new positions and closed 227 in Q3 2025.
  • Los Angeles Capital Management's portfolio value rose 10% quarter-over-quarter to $29.5B.

Based on Los Angeles Capital Management's 13F filing for Q3 2025, filed 20 Oct 2025.